SciSparc Ltd.

0.92 USD
+0.02 (+2.22%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

SciSparc Ltd. stock is down -24.59% since 30 days ago. The next earnings date is Jun 28, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 2 June’s closed higher than May.

About SciSparc Ltd.

SciSparc Ltd. develops drugs based on cannabinoid molecules. Its drug development programs include SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea, and Alzheimer's disease and agitation. SCi-160 for the. treatment of pain; SCII-210 for the. treatment of autism spectrum disorder and epilepsy. The company was formerly known as Therapix Biosciences.